- Home
- INKT vs HHS Comparison
INKT vs HHS Comparison
Compare INKT & HHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INKT
- HHS
- Stock Information
- Founded
- INKT 2017
- HHS 1923
- Country
- INKT United States
- HHS United States
- Employees
- INKT N/A
- HHS N/A
- Industry
- INKT Medicinal Chemicals and Botanical Products
- HHS Advertising
- Sector
- INKT Health Care
- HHS Consumer Discretionary
- Exchange
- INKT Nasdaq
- HHS Nasdaq
- Market Cap
- INKT 33.6M
- HHS 37.0M
- IPO Year
- INKT 2021
- HHS N/A
- Fundamental
- Price
- INKT $9.03
- HHS $4.67
- Analyst Decision
- INKT Strong Buy
- HHS
- Analyst Count
- INKT 2
- HHS 0
- Target Price
- INKT $37.50
- HHS N/A
- AVG Volume (30 Days)
- INKT 10.0K
- HHS 25.9K
- Earning Date
- INKT 03-18-2025
- HHS 03-17-2025
- Dividend Yield
- INKT N/A
- HHS N/A
- EPS Growth
- INKT N/A
- HHS N/A
- EPS
- INKT N/A
- HHS N/A
- Revenue
- INKT N/A
- HHS $185,242,000.00
- Revenue This Year
- INKT N/A
- HHS $6.54
- Revenue Next Year
- INKT N/A
- HHS N/A
- P/E Ratio
- INKT N/A
- HHS N/A
- Revenue Growth
- INKT N/A
- HHS N/A
- 52 Week Low
- INKT $4.56
- HHS $4.27
- 52 Week High
- INKT $19.00
- HHS $8.87
- Technical
- Relative Strength Index (RSI)
- INKT 53.66
- HHS 43.52
- Support Level
- INKT $7.81
- HHS $4.37
- Resistance Level
- INKT $9.23
- HHS $4.89
- Average True Range (ATR)
- INKT 0.85
- HHS 0.44
- MACD
- INKT 0.11
- HHS 0.00
- Stochastic Oscillator
- INKT 68.66
- HHS 40.02
Stock Price Comparison Chart: INKT vs HHS
■ INKT
■ HHS
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.
About HHS Harte-Hanks Inc.
Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.